Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillActive in the last 2 years

James D. Byrne

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6436-2866; OpenAlex author ID A5088498661. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Potentiating the effect of immunotherapy in pancreatic cancer using gas-entrapping materials. Last author DOI 10.1016/j.biomaterials.2025.123097↗
  2. Impact of formulation on the iontophoretic delivery of the FOLFIRINOX regimen for the treatment of pancreatic cancer. Co-author DOI 10.1007/s00280-018-3570-3↗
  3. Iontophoretic device delivery for the localized treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1073/pnas.1600421113↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianling Bi · 1 shared paper, 2025 · strength 0.19
  2. Juan Du · 1 shared paper, 2025 · strength 0.19
  3. Carlos H.F. Chan · 1 shared paper, 2025 · strength 0.19
  4. William C Zamboni · 2 shared papers, 2016–2018 · strength 0.14
  5. Jen Jen Yeh · 2 shared papers, 2016–2018 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.